Global-PPSについて

The Global Point Prevalence Survey of Antimicrobial Consumption and Resistance (Global-PPS) offers a simple, freely available web-based tool to measure and monitor antimicrobial prescribing and resistance in hospitals and healthcare centers worldwide. The Global-PPS has established a global network of hospitals conducting point prevalence surveys and provides quantifiable measures to assess and compare quantity and quality of antimicrobial prescribing and resistance in in- and outpatient adults, children and neonates worldwide. The Global-PPS creates global awareness about antibiotic use and resistance and is instrumental in planning and supporting national and local stewardship interventions in a range of resource and geographical settings.

Main aims - Critical benefits for the healthcare centers?

GLOBAL-PPSは次の目的を実行するためのツールを提供します。

  • Evaluate antimicrobial prescribing practices and survey performance indicators in healthcare centers ((負担の特定),
  • Help designing local interventions and identifying targets for quality improvement of antimicrobial prescribing and the prevention of Healthcare-Associated Infections (HAI) (change practice),
  • PPSを繰り返し行って介入の有効性を評価する（影響の測定評価。

提供されるフィードバック

After finalization of data entry and validation, the healthcare center will be able to download a feedback report which can be used for local communications and presentations. Healthcare center-specific antimicrobial prevalence figures will be plotted against overall mean national and continental results. The feedback also provides information on several antibiotic quality indicators. Users can receive longitudinal feedback based on the results of their completed surveys via the interactive feature of the application.

On top of that, institutions can at any time extract their own data in an Excel file. These data can be analyzed for own purposes.

データ

Data collection implies conducting a “one day survey” including:

  1. For inpatient departments: hospitalized inpatients at 8 o’clock on the day of the PPS whereby detailed data is collected for those patients receiving an antimicrobial treatment.
  2. For outpatient departments: all outpatients seen during a timeslot of at least half a day on the day of the PPS, whereby brief information is collected for all patients and more detailed data for patients receiving an antimicrobial treatment.

Data are collected on paper forms, and subsequently entered in a database using the Global-PPS tool, a web-based application for data entry, validation and reporting. For outpatient departments, it is additionally possible to collect data real-time, by entering the information in the website during patient visits.

For inpatient departments, essential data to collect are the patients’ age and gender, antimicrobial agent, dose per administration, number of doses per day and route of administration. Besides antibiotics, also antifungals, antimycotics, antivirals, antibiotics for the treatment of tuberculosis and antimalarials are surveyed. Other mandatory variables include the anatomical site of infection or prophylaxis according to a list of provided reasons for treatment or prophylaxis, indication for therapy (community versus hospital acquired infection or prophylaxis) and whether the treatment choice is determined by detected micro-organisms and available microbiological or biomarker data. For the optional HAI module, extra details on invasive devices are collected (e.g. peripheral vascular catheter, indwelling urinary catheter etc.).

分母となるデータは、各診療科における入院患者数と病床数です。

For outpatient departments, essential data to collect are the patients’ age category, gender and presenting symptoms. Data on admission status should be additionally collected for emergency and observation departments. More detailed information should be collected for each patient receiving antimicrobial treatment. This includes information on their specific age and underlying morbidities, as well as treatment-related information, such as the specific antimicrobial agent, dose per administration, number of doses per day, route of administration, anatomical site of infection, indication of therapy (community- versus hospital-acquired infection or prophylaxis), whether the treatment was based on a Point-of-Care test, Rapid Diagnostic Test or biomarker and whether local guidelines are available for the prescribed treatment.

Denominator data are the number of patients that visited the department in the surveyed timeslot on the day of the PPS.

皆さんの本プロジェクトへの参加を心待ちにしています。

Sign me up

予想されるスケジュール

Three surveys are available each year (January-April, May-August and Septem­ber-December). Hospitals can choose to participate in one to maximum three surveys a year. As such, they can follow up on interventions or investigate for example seasonal variation.

Any hospital worldwide is welcome to participate. Bigger hospitals who have participated at least once in the Global-PPS are able to participate with a sub­sample of the hospital whereby a set of certain ward types can be targeted (e.g. all ICUs, all surgical or all paediatric wards). 

重要な点

データは完全に匿名でGlobal-PPSツールにオンライン入力され、アントワープ大学のESACサーバで保護されます。その後のデータの所有権は病院が保持したままとなります。ビオメリューがこれらのデータにアクセスすることはなく、アントワープ大学がビオメリューを含む第三者に病院名を開示することもありません。病院の参加や実地調査はいずれも任意で行われるものです。Global-PPSチームは、「地域の共同参加施設」や「国または地方のPPS参加施設」を主導し、地方または国に固有の分析を行うよう推奨しています。論文発表に関するポリシーが作成されています（文書をご覧ください）。

重要

Since the introduction of the new outpatient protocoll in 2023, there are now three ways of collecting data possible:

  • The original, basic PPS allows to survey antimicrobial use in inpatient settings, Healthcare-Associated Infections (HAI) and Antimicrobial Resistance.
  • The full version of the PPS including an extra HAI module allows to survey invasive device use in more detail for inpatients. In addition to the basic PPS, one extra form per patient on antimicrobials needs to be completed. The extra HAI module is completely optional.
  • The outpatient version of the PPS allows to survey antimicrobial use in the outpatient.

Both in- and outpatient wards can be surveyed simultaneously using the respective modules.